Company BCAL Diagnostics Limited
Equities
BDX
AU0000160921
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.092 AUD | -3.16% | -8.00% | -7.07% |
Mar. 06 | BCAL Diagnostics Appoints CEO | MT |
Feb. 20 | BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shane Ryan
CEO | Chief Executive Officer | - | 23-09-20 |
Guy Robertson
DFI | Director of Finance/CFO | 70 | - |
Chief Tech/Sci/R&D Officer | - | 22-03-31 | |
Amani Batarseh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Director/Board Member | 75 | 22-02-13 | |
Rebecca Shaw
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Jayne Shaw
FOU | Founder | - | 09-12-31 |
Director/Board Member | 75 | 22-02-13 | |
Jonathan Trollip
BRD | Director/Board Member | - | 20-12-22 |
Founder | - | 09-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 251,639,158 | 116,377,616 ( 46.25 %) | 0 | 46.25 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.07% | 15.63M | |
+1.69% | 12.8B | |
-7.57% | 7.61B | |
+3.22% | 5.41B | |
+0.93% | 4.51B | |
+8.35% | 4.49B | |
+9.21% | 2.73B | |
-13.87% | 2.02B | |
-11.63% | 1.73B | |
+1.15% | 1.64B |
- Stock Market
- Equities
- BDX Stock
- Company BCAL Diagnostics Limited